SCHEMBL23484271

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL14445522	0.83	TSHR (0.47)	CA12CA1CA2CA7CA9
	SCHEMBL28654509	0.81	CA12 (0.56)	CA12CA1CA2CA7CA9
	SCHEMBL22023506	0.79	LMNA (0.45)	PKMCYP3A4SMN1; SMN2TDP1NR1H2
	SCHEMBL16302043	0.78	TSHR (0.61)	CA12CA1CA2CA7CA9
	SCHEMBL13898549	0.78	CA12 (0.50)	CA12CA1CA2CA7CA9
	SCHEMBL18311390	0.78	CA12 (0.53)	CA12CA1CA2CA7CA9
	SCHEMBL8945912	0.78	MAPT (0.57)	PKMCYP3A4GAAMAPTLMNA
	SCHEMBL29382216	0.78	MAPT (0.57)	PKMCYP3A4GAAMAPTLMNA
	SCHEMBL27538691	0.78	LMNA (0.53)	PKMCYP3A4GAAMAPTLMNA
	SCHEMBL4316932	0.77	CA12 (0.68)	CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.